Tao Kai, Ye Lu, Xu Yan-Jia-Ni, Yang Meng-Xi, Yin Ru-Tie, Li Qing-Li, Lin Xiao-Juan, Li Ke-Min, Song Liang, Ma Yu, Zhong Lan, Hu Ying, Xu Hua-Yan, Wang Dan-Qing, Guo Ying-Kun
Department of Radiology, Key Laboratory of Birth Defects and Related Diseases of Women and Children of Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu, China.
West China School of Medicine, West China Hospital, Sichuan University, Chengdu, China.
Front Oncol. 2025 Feb 3;15:1464368. doi: 10.3389/fonc.2025.1464368. eCollection 2025.
Chemotherapy-induced cardiotoxicity is a concern for patients with gynecologic cancer. This study aimed to assess left ventricular (LV) myocardial deformation in patients with gynecologic cancer undergoing chemotherapy and to investigate the association between myocardial deformation and chemotherapy factors.
Cardiac magnetic resonance (CMR) was performed to assess LV deformation parameters using CMR tissue tracking based on cine images. Serum myocardial injury biomarker were measured. Deformation parameters were compared between healthy controls and patients. Changes in deformation were assessed as chemotherapy progressed. Correlations between LV deformation parameters, clinical characteristics, and serum myocardial injury biomarkers were also analyzed.
A total of 86 patients with gynecologic cancer and 30 normal controls were included. Among the patients, 41 completed CMR follow-up with a median interval of 6 months. Compared to the controls, patients exhibited lower absolute value of global radial strain (GRS) (37.30 ± 8.94% vs. 44.32 ± 8.44%), global circumferential strain (GCS) (-22.12 ± 3.05% vs. -24.08 ± 2.13%) and global longitudinal strain (GLS) (median -15.72% [IQR-17.13 to -13.58%] vs. -17.51 ± 2.00 %) (all < 0.05). Patients with preserved LV ejection fraction (LVEF) also showed impaired global strain (all < 0.05). GRS (39.71 ± 8.09% vs. median 30.56% [IQR 26.52 to 38.15%]; = 0.001), GCS (-23.45 ± 2.09% vs. median -19.71% [IQR -21.71 to -19.10%]; < 0.001) and GLS (-16.17 ± 2.42% vs. median -12.12% [IQR -14.10 to -8.53%]; < 0.001) further decreased as the number of chemotherapy cycles increased during follow-up (all < 0.05). Multivariate analysis showed that GCS was independently associated with the number of chemotherapy regimens (Standard regression coefficient [β] = 0.397, < 0.001).
Myocardial deformation is more sensitive than LVEF in detecting subclinical left ventricular dysfunction in patients with gynecologic cancer undergoing chemotherapy. GCS was associated with the number of chemotherapy regimens.
化疗引起的心脏毒性是妇科癌症患者关注的问题。本研究旨在评估接受化疗的妇科癌症患者的左心室(LV)心肌变形,并探讨心肌变形与化疗因素之间的关联。
采用心脏磁共振成像(CMR),基于电影图像通过CMR组织追踪技术评估左心室变形参数。检测血清心肌损伤生物标志物。比较健康对照者与患者的变形参数。随着化疗的进行评估变形的变化。还分析了左心室变形参数、临床特征和血清心肌损伤生物标志物之间的相关性。
共纳入86例妇科癌症患者和30例正常对照者。其中,41例患者完成了CMR随访,中位间隔时间为6个月。与对照组相比,患者的整体径向应变(GRS)绝对值较低(37.30±8.94%对44.32±8.44%)、整体圆周应变(GCS)较低(-22.12±3.05%对-24.08±2.13%)和整体纵向应变(GLS)较低(中位数-15.72%[四分位间距-17.13至-13.58%]对-17.51±2.00%)(均P<0.05)。左心室射血分数(LVEF)保留的患者也表现出整体应变受损(均P<0.05)。在随访期间,随着化疗周期数的增加,GRS(39.71±8.09%对中位数30.56%[四分位间距26.52至38.15%];P = 0.001)、GCS(-23.45±2.09%对中位数-19.71%[四分位间距-21.71至-19.10%];P<0.001)和GLS(-16.17±2.42%对中位数-12.12%[四分位间距-14.10至-8.53%];P<0.001)进一步降低(均P<0.05)。多因素分析显示,GCS与化疗方案数独立相关(标准回归系数[β]=0.397,P<0.001)。
在检测接受化疗的妇科癌症患者的亚临床左心室功能障碍方面,心肌变形比LVEF更敏感。GCS与化疗方案数相关。